SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $119,595 | -47.3% | 134,983 | -6.6% | 0.00% | -100.0% |
Q3 2022 | $227,000 | -21.7% | 144,483 | +0.2% | 0.00% | 0.0% |
Q2 2022 | $290,000 | -22.9% | 144,233 | -10.5% | 0.00% | 0.0% |
Q1 2022 | $376,000 | -45.7% | 161,195 | +8.2% | 0.00% | 0.0% |
Q4 2021 | $693,000 | -57.8% | 148,931 | -30.8% | 0.00% | -66.7% |
Q3 2021 | $1,642,000 | -11.0% | 215,161 | +13.1% | 0.00% | -25.0% |
Q2 2021 | $1,844,000 | +24.3% | 190,254 | +6.1% | 0.00% | +33.3% |
Q1 2021 | $1,483,000 | +50.4% | 179,336 | +24.1% | 0.00% | +50.0% |
Q4 2020 | $986,000 | -62.8% | 144,522 | -39.2% | 0.00% | -75.0% |
Q3 2020 | $2,648,000 | +633.5% | 237,528 | +312.9% | 0.01% | +700.0% |
Q2 2020 | $361,000 | +1469.6% | 57,523 | +357.4% | 0.00% | – |
Q1 2020 | $23,000 | -36.1% | 12,577 | +19.5% | 0.00% | – |
Q4 2019 | $36,000 | +33.3% | 10,527 | -15.5% | 0.00% | – |
Q3 2019 | $27,000 | -18.2% | 12,459 | 0.0% | 0.00% | – |
Q2 2019 | $33,000 | -44.1% | 12,459 | 0.0% | 0.00% | – |
Q1 2019 | $59,000 | – | 12,459 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
Trexquant Investment LP | 67,929 | $592,000 | 0.05% |